ono 1078 has been researched along with prostaglandin f1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, S; Hashimoto, M; Kaneko, S; Kurokawa, K; Miyazaki, N; Saito, T; Tanaka, H; Teramoto, S | 1 |
1 trial(s) available for ono 1078 and prostaglandin f1
Article | Year |
---|---|
Leukotriene (LT)-receptor antagonist is more effective in asthmatic patients with a low baseline ratio of urinary LTE4 to 2,3-dinor-6-keto-prostaglandin (PG)F1alpha.
Topics: Adult; Aged; Anti-Asthmatic Agents; Asthma; Chromones; Female; Humans; Leukotriene Antagonists; Leukotriene E4; Male; Middle Aged; Peak Expiratory Flow Rate; Prostaglandins F; Thromboxane B2 | 1999 |